With its innovative approach, tirzepatide is poised to become a cornerstone therapy for managing T2DM and obesity
Antihistamines and decongestants may also slow breast milk production
Tirzepatide is self-administered as a subcutaneous (under the skin) injection using a single-dose pen, KwikPen, or vial with syringe, and should always be used together with diet and exercise
A qualified provider will walk you through every step, from dosing to application, so you can feel confident and cared for throughout your journey
Side effects: Like semaglutide, tirzepatides most common side effects are nausea, diarrhea, vomiting, stomach pain, and indigestion
Horm Metab Res (2004) 36:8528